Feed aggregator

BCS Investors Have Opportunity to Join Barclays PLC Fraud Investigation with the Schall Law Firm

Lastest from Businesswire - Sun, 03/08/2026 - 22:53
LOS ANGELES--(BUSINESS WIRE)---- $BCS--BCS Investors Have Opportunity to Join Barclays PLC Fraud Investigation with the Schall Law Firm

ELWT Investors Have Opportunity to Join Elauwit Connection, Inc. Fraud Investigation with the Schall Law Firm

Lastest from Businesswire - Sun, 03/08/2026 - 22:53
LOS ANGELES--(BUSINESS WIRE)---- $ELWT--ELWT Investors Have Opportunity to Join Elauwit Connection, Inc. Fraud Investigation with the Schall Law Firm

EAF Investors Have Opportunity to Join GrafTech International Ltd. Fraud Investigation with the Schall Law Firm

Lastest from Businesswire - Sun, 03/08/2026 - 22:53
LOS ANGELES--(BUSINESS WIRE)---- $EAF--EAF Investors Have Opportunity to Join GrafTech International Ltd. Fraud Investigation with the Schall Law Firm

BSX Investors Have Opportunity to Join Boston Scientific Corporation Fraud Investigation with the Schall Law Firm

Lastest from Businesswire - Sun, 03/08/2026 - 22:53
LOS ANGELES--(BUSINESS WIRE)---- $BSX--BSX Investors Have Opportunity to Join Boston Scientific Corporation Fraud Investigation with the Schall Law Firm

DINO Investors Have Opportunity to Join HF Sinclair Corporation Fraud Investigation with the Schall Law Firm

Lastest from Businesswire - Sun, 03/08/2026 - 22:53
LOS ANGELES--(BUSINESS WIRE)---- $DINO--DINO Investors Have Opportunity to Join HF Sinclair Corporation Fraud Investigation with the Schall Law Firm

BFAM Investors Have Opportunity to Join Bright Horizons Family Solutions Inc. Fraud Investigation with the Schall Law Firm

Lastest from Businesswire - Sun, 03/08/2026 - 22:53
LOS ANGELES--(BUSINESS WIRE)---- $BFAM--BFAM Investors Have Opportunity to Join Bright Horizons Family Solutions Inc. Fraud Investigation with the Schall Law Firm

RUN Investors Have Opportunity to Join Sunrun Inc. Fraud Investigation with the Schall Law Firm

Lastest from Businesswire - Sun, 03/08/2026 - 19:53
LOS ANGELES--(BUSINESS WIRE)---- $RUN--RUN Investors Have Opportunity to Join Sunrun Inc. Fraud Investigation with the Schall Law Firm

PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm

Lastest from Businesswire - Sun, 03/08/2026 - 19:53
LOS ANGELES--(BUSINESS WIRE)---- $PRCT--PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm

Phillips 66 Appoints Howard Ungerleider and Kevin Meyers to Board of Directors

Lastest from Businesswire - Sun, 03/08/2026 - 13:53
HOUSTON--(BUSINESS WIRE)--Phillips 66 today announced that it has appointed Howard Ungerleider and Kevin Meyers to serve on the Company’s Board of Directors.

CRWV Deadline: Rosen Law Firm Urges CoreWeave, Inc. (NASDAQ: CRWV) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Lastest from Businesswire - Sun, 03/08/2026 - 10:53
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of CoreWeave, Inc. (NASDAQ: CRWV) between March 28, 2025 and December 15, 2025. CoreWeave describes itself as an “an AI cloud computing company.” For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that CoreWeave, Inc. (NAS

Investor Notice: Robbins LLP Informs Investors of the Soleno Therapeutics, Inc. Class Action Lawsuit

Lastest from Businesswire - Fri, 03/06/2026 - 21:52
SAN DIEGO--(BUSINESS WIRE)---- $SLNO #SolenoTherapeuticsInc--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Soleno Therapeutics (NASDAQ: SLNO) common stock between March 26, 2025 and November 4, 2025. Soleno is a pharmaceutical company focused on developing therapies for rare diseases. The Company’s only commercial product is diazoxide choline extended-release tablets (“DCCR”) for the treatment of hyperphagia in individuals afflicted with Prader-Wil

Investor Notice: Robbins LLP Informs Investors of the Eos Energy Enterprises, Inc. Class Action Lawsuit

Lastest from Businesswire - Fri, 03/06/2026 - 18:52
SAN DIEGO--(BUSINESS WIRE)---- $EOSE #Energy--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Eos Energy Enterprises, Inc. (NASDAQ: EOSE) securities between November 5, 2025 and February 26, 2026. Eos Energy designs, manufactures, and markets zinc-based battery energy storage systems intended for utility-scale commercial and industrial applications. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call

ON24 Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of ON24, Inc. - ONTF

Lastest from Businesswire - Fri, 03/06/2026 - 18:52
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ON24, Inc. (NYSE: ONTF) to Cvent. Under the terms of the proposed transaction, shareholders of ON24 will receive $8.10 in cash for each share of ON24 that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration underv

Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN

Lastest from Businesswire - Fri, 03/06/2026 - 18:52
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Day One Biopharmaceuticals, Inc. (NasdaqGS: DAWN) to Servier. Under the terms of the proposed transaction, shareholders of Day One will receive $21.50 in cash for each share of Day One that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate,

Flushing Financial Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Flushing Financial Corp. - FFIC

Lastest from Businesswire - Fri, 03/06/2026 - 18:52
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Flushing Financial Corp. (NasdaqGS: FFIC) to OceanFirst Financial Corp. (NasdaqGS: OCFC). Under the terms of the proposed transaction, shareholders of Flushing Financial will receive 0.85 of a share of OceanFirst common stock for each share of Flushing Financial that they own. KSF is seeking to dete

United Security Bancshares Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of United Security Bancshares - UBFO

Lastest from Businesswire - Fri, 03/06/2026 - 18:52
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of United Security Bancshares (NasdaqGS: UBFO) to Community West Bancshares (NasdaqCM: CWBC). Under the terms of the proposed transaction, shareholders of United will receive 0.4520 shares of Community West for each share of United that they own. KSF is seeking to determine whether this consideration a

Ardent Health 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Ardent Health, Inc. - ARDT

Lastest from Businesswire - Fri, 03/06/2026 - 18:52
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT), if they purchased or otherwise acquired the Company’s securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). This

Law Offices of Howard G. Smith Encourages Eos Energy Enterprises (EOSE) Investors to Inquire About Securities Fraud Class Action

Lastest from Businesswire - Fri, 03/06/2026 - 18:52
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Eos Energy Enterprises (“Eos Energy” or the “Company”) (NASDAQ: EOSE) securities between November 5, 2025 and February 26, 2026, inclusive (the “Class Period”). Eos Energy investors have until May 5, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN EOS ENERGY ENTERPRISES (EOSE), CONTACT THE LAW OFFICES OF HOWA

EOSE DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Eos Energy Enterprises (EOSE) Investors of Securities Class Action Deadline on May 5, 2026

Lastest from Businesswire - Fri, 03/06/2026 - 18:52
NEW YORK--(BUSINESS WIRE)---- $EOSE #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Eos Energy Enterprises, Inc. (“EOS Energy” or the “Company”) (NASDAQ: EOSE) and reminds investors of the May 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

Lastest from Businesswire - Fri, 03/06/2026 - 18:52
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities enumerated below (“Securities”) of Allurion Technologies, Inc. (the “Company”) from the NYSE. NYSE Regulation reached its decision to commence proceedings to delist the Company’s Securities pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s

Pages